Cerapedics, a privately-held orthobiologics company, announced today results from a pivotal FDA Investigational Device Exemption (IDE) clinical trial for i-FACTOR™ Peptide Enhanced Bone Graft in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback